Literature DB >> 12517817

High incidence of t(11;18)(q21;q21) in Helicobacter pylori-negative gastric MALT lymphoma.

Hongtao Ye1, Hongxiang Liu, Markus Raderer, Andreas Chott, Agnes Ruskone-Fourmestraux, Andrew Wotherspoon, Martin J S Dyer, Shih-Sung Chuang, Ahmet Dogan, Peter G Isaacson, Ming-Qing Du.   

Abstract

In approximately 5% to 10% of gastric mucosa-associated lymphoid tissue (MALT) lymphomas, evidence of Helicobacter pylori infection is absent, and their pathogenesis is poorly understood. We reviewed the clinical data and histology, and we examined t(11;18)(q21;q21) and BCL10 expression pattern in 17 such cases. In each case, the absence of H pylori was confirmed by negative serology and histology/immunohistochemistry. Five cases with stage I(E) disease were first treated with antibiotics, and none of them showed any endoscopic or histologic response. Review of the histology failed to identify any apparent difference between gastric MALT lymphomas with and without H pylori infection. Reverse transcription-polymerase chain reaction (RT-PCR) showed t(11;18)(q21;q21) in 9 (53%) of 17 cases, more frequent in lymphomas at stage II(E) or above (5 of 6) than those at stage I(E) (3 of 10). Two t(11;18)(q21;q21)-positive lymphomas were treated by partial gastrectomy and more than 16 years later showed lymphoma relapse in the gastric stump with dissemination to other mucosal sites, poorly responsive to therapy. BCL10 nuclear expression was observed in 7 of 8 t(11;18)(q21;q21)-positive cases and 4 of 7 t(11;18)(q21;q21)-negative cases, including one case suspicious for a BCL10-involved chromosomal translocation. Our results show that t(11;18)(q21;q21) occurs at a high frequency in H pylori-negative gastric MALT lymphomas. Translocation-positive gastric MALT lymphomas tend to be aggressive, and patients with such lymphomas might benefit from prompt treatment and close follow-up.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12517817     DOI: 10.1182/blood-2002-10-3167

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  26 in total

1.  H. pylori negative MALT lymphoma patients successfully treated with antibiotics: doubts about their H. pylori negativity.

Authors:  E Lahner; M Milione; G Delle Fave; B Annibale
Journal:  Gut       Date:  2006-11       Impact factor: 23.059

2.  Successful antibiotic treatment of Helicobacter pylori negative gastric mucosa associated lymphoid tissue lymphomas.

Authors:  M Raderer; B Streubel; S Wöhrer; M Häfner; A Chott
Journal:  Gut       Date:  2005-11-18       Impact factor: 23.059

Review 3.  Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphomas: A review.

Authors:  Naoki Asano; Katsunori Iijima; Tomoyuki Koike; Akira Imatani; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

4.  Treatment outcome of localized Helicobacter pylori-negative low-grade gastric MALT lymphoma.

Authors:  Hyung Soon Park; Yu Jin Kim; Woo Ick Yang; Chang Ok Suh; Yong Chan Lee
Journal:  World J Gastroenterol       Date:  2010-05-07       Impact factor: 5.742

Review 5.  Heavy Chain Disease of the Small Bowel.

Authors:  Giada Bianchi; Aliyah R Sohani
Journal:  Curr Gastroenterol Rep       Date:  2018-01-25

Review 6.  Marginal Zone Lymphoma: Clinicopathologic Variations and Approaches to Therapy.

Authors:  Sabarish Ayyappan; Basem M William
Journal:  Curr Oncol Rep       Date:  2018-03-23       Impact factor: 5.075

Review 7.  Malt1 and cIAP2-Malt1 as effectors of NF-kappaB activation: kissing cousins or distant relatives?

Authors:  Lara M Kingeter; Brian C Schaefer
Journal:  Cell Signal       Date:  2009-09-19       Impact factor: 4.315

8.  Concerns about the Predictive Factors for Tumor Regression, Definition, and Management of Nonresponders, and Relapse of Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Related to Helicobacter pylori.

Authors:  Sun-Young Lee
Journal:  Gut Liver       Date:  2009-09-30       Impact factor: 4.519

9.  Clinical outcomes of radiation therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma.

Authors:  Sang-Won Kim; Do Hoon Lim; Yong Chan Ahn; Won Seog Kim; Seok Jin Kim; Young Hyeh Ko; Kyoung-Mee Kim
Journal:  World J Gastroenterol       Date:  2013-09-28       Impact factor: 5.742

10.  Two Cases of Diffuse Large B-Cell Lymphomas in the Cervical Lymph Nodes in Patients with Low-Grade Gastric Marginal Zone B-Cell Lymphoma (MALT Lymphoma).

Authors:  Ji Hoon Jung; Hwoon-Yong Jung; Hwan Yoon; Jae Kwang Lee; Ji Hoon Kang; Sung Jin Jeon; Young-Su Park; Jin-Ho Kim
Journal:  Clin Endosc       Date:  2013-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.